INOFLO

Table of contents:

The "INOFLO" trademark, serial number 77689471 , was filed on 12th of March 2009 with a mark drawing code of 4000 and its transaction date is 77689471. The attorney assigned is Maribeth Day Case, attorney docket number TMR/5057981/. Since 22nd of March 2012, the document can be found in the M70 law office in the publication and issue section. The employee responsible is BURNS, ELLEN FERRER and the date it was published for opposition on 06/30/2009. The status of this trademark was checked last on 08/16/2011.

The "INOFLO" trademark, serial number 85489160 , was filed on 7th of December 2011 with a mark drawing code of 4000 and its transaction date is 85489160. The attorney assigned is Maribeth Day Case, attorney docket number TMR/5082119/. Since 10th of July 2012, the document can be found in the L90 law office in the publication and issue section. The employee responsible is MARCY, AMY ALFIERI and the date it was published for opposition on 05/15/2012. The date when we last checked the status of this trademark was 07/10/2012.

The corresponded responsible for this trademark is MARIBETH DAY CASE, located at GLAXOSMITHKLINE, 5 MOORE DR, RESEARCH TRIANGLE PARK, NC 27709-0183.

The state or country where the trademark was organized is by Glaxo Group Limited. The legal entity type behing it is a Corporation, located at Glaxo Wellcome House, Greenford, Middlesex, zip UB60NN.Other trademarks by this applicant: EDOZAB, EDIZAB, ENUMIRE.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date12/13/2011
Primary Code005
Goods codes
GS0051Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, urological, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immunological diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
PROSECUTION HISTORY
DateDescriptionTypeCode
07/10/2012 NOA E-MAILED - SOU REQUIRED FROM APPLICANT E NOAM
05/15/2012 OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED E NPUB - NOTICE OF PUBLICATION
05/15/2012 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
04/25/2012 NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED E NONP
04/10/2012 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2012 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
03/19/2012 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2012 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
12/13/2011 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
12/10/2011 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.